1. Home
  2. PTIX vs BBLG Comparison

PTIX vs BBLG Comparison

Compare PTIX & BBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTIX
  • BBLG
  • Stock Information
  • Founded
  • PTIX 1994
  • BBLG 2004
  • Country
  • PTIX United States
  • BBLG United States
  • Employees
  • PTIX N/A
  • BBLG N/A
  • Industry
  • PTIX Biotechnology: Pharmaceutical Preparations
  • BBLG Industrial Specialties
  • Sector
  • PTIX Health Care
  • BBLG Health Care
  • Exchange
  • PTIX Nasdaq
  • BBLG Nasdaq
  • Market Cap
  • PTIX 3.9M
  • BBLG 3.3M
  • IPO Year
  • PTIX 2016
  • BBLG N/A
  • Fundamental
  • Price
  • PTIX $0.64
  • BBLG $1.16
  • Analyst Decision
  • PTIX
  • BBLG
  • Analyst Count
  • PTIX 0
  • BBLG 0
  • Target Price
  • PTIX N/A
  • BBLG N/A
  • AVG Volume (30 Days)
  • PTIX 247.6K
  • BBLG 173.7K
  • Earning Date
  • PTIX 11-29-2024
  • BBLG 11-26-2024
  • Dividend Yield
  • PTIX N/A
  • BBLG N/A
  • EPS Growth
  • PTIX N/A
  • BBLG N/A
  • EPS
  • PTIX N/A
  • BBLG N/A
  • Revenue
  • PTIX N/A
  • BBLG N/A
  • Revenue This Year
  • PTIX N/A
  • BBLG N/A
  • Revenue Next Year
  • PTIX N/A
  • BBLG N/A
  • P/E Ratio
  • PTIX N/A
  • BBLG N/A
  • Revenue Growth
  • PTIX N/A
  • BBLG N/A
  • 52 Week Low
  • PTIX $0.49
  • BBLG $0.80
  • 52 Week High
  • PTIX $1.87
  • BBLG $10.56
  • Technical
  • Relative Strength Index (RSI)
  • PTIX 49.61
  • BBLG 37.96
  • Support Level
  • PTIX $0.52
  • BBLG $1.14
  • Resistance Level
  • PTIX $1.09
  • BBLG $1.39
  • Average True Range (ATR)
  • PTIX 0.15
  • BBLG 0.14
  • MACD
  • PTIX 0.01
  • BBLG -0.02
  • Stochastic Oscillator
  • PTIX 20.91
  • BBLG 3.48

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About BBLG Bone Biologics Corp

Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.

Share on Social Networks: